Brief: Medicenna Therapeutics Announces Key Program Updates And 2026 Outlook
15/01/2026 12:35
Jan 15 (Reuters) - Medicenna Therapeutics Corp MDNA.TO: MEDICENNA THERAPEUTICS ANNOUNCES KEY PROGRAM UPDATES AND 2026 OUTLOOK MEDICENNA THERAPEUTICS CORP - IND SUBMISSION FOR MDNA113 EXPECTED IN H2 2026 MEDICENNA THERAPEUTICS CORP - UPDATED CASH GUIDANCE PROVIDES RUNWAY INTO Q3 2026 Source text: ID:nGNX8TR2nF Further company coverage: MDNA.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results